HighCycle Study: Effect of High Altitude on Sleep Disordered Breathing in Women Related to Their Menstrual Cycle Phase

NCT ID: NCT06498544

Last Updated: 2025-06-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-07-15

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Prospective cohort study investigating the menstrual cycle phase (MCP) dependent sleep disordered breathing (SDB) in women travelling to 3600 m.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep-Disordered Breathing

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Women in luteal MCP

Women being in their luteal MCP on the day of ascent to high altitude.

Exposure to 3600 m

Intervention Type OTHER

Participants will travel to and stay for 2 nights at an altitude of 3600 m.

Women in follicular MCP

Women being in their follicular MCP on the day of ascent to high altitude.

Exposure to 3600 m

Intervention Type OTHER

Participants will travel to and stay for 2 nights at an altitude of 3600 m.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exposure to 3600 m

Participants will travel to and stay for 2 nights at an altitude of 3600 m.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy, non-smoking women, age 18-44 years, without any diseases and need of regular medication (including oral contraceptives).
* BMI \>18 kg/m2 and \<30 kg/m2
* Born, raised and currently living at altitudes \<1000 m
* Written informed consent
* Premenopausal, eumenorrheic cycle

Exclusion Criteria

* Other types of contraceptives (hormonal intrauterine device, vaginal ring, subcutaneous injections or implants, among others)
* Pregnancy or nursing
* Anaemic (haemoglobin concentration \<10g/dl)
* Any altitude trip \<4 weks before the study
* Allergy to acetazolamide and other sulfonamides
Minimum Eligible Age

18 Years

Maximum Eligible Age

44 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Center of Cardiology and Internal Medicine named after academician M.Mirrakhimov

OTHER_GOV

Sponsor Role collaborator

University Hospital Heidelberg

OTHER

Sponsor Role collaborator

Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques

OTHER

Sponsor Role collaborator

University of Zurich

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael Furian, Prof. Dr.

Role: STUDY_CHAIR

University of Zurich

Talant Sooronbaev, Prof. Dr.

Role: STUDY_DIRECTOR

National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Center for Cardiology and Internal Medicine

Bishkek, Gorod Bishkek, Kyrgyzstan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Kyrgyzstan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Michael Furian, Prof. Dr.

Role: CONTACT

+41794037586

Talant Sooronbaev, Prof. Dr.

Role: CONTACT

+996772574567

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Talant M Sooronbaev, MD

Role: primary

+996 312 625679

Konrad E Bloch, MD

Role: backup

+44 255 38 28

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HighCycle_SDB_MCP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Home Sleep and Metabolism
NCT02253368 COMPLETED NA
Vital Signs Reduction Study
NCT06865781 ACTIVE_NOT_RECRUITING NA